A number of state legislatures are considering bills banning synthetic drugs, requiring education for doctors who prescribe opioids, and expanding the use of the drug overdose antidote naloxone this session, explains Sherry Green, CEO of the National Alliance for Model State Drug Laws.
Category results for "Prescription Drugs"
Food and Drug Administration Commissioner Margaret Hamburg defended the agency’s decision to approve the pure hydrocodone drug Zohydro ER (extended release). At a Senate hearing, Hamburg said, “If appropriately used, it serves an important and unique niche with respect to pain medication and it meets the standards for safety and efficacy.”
The maker of OxyContin announced promising results from a study of a tamper-resistant form of hydrocodone, The Washington Post reports. The Food and Drug Administration has been criticized for approving Zohydro ER (extended release), a pure form of hydrocodone that is not tamper-resistant.
The effectiveness of prescription drug monitoring programs, designed to reduce “doctor shopping” for opioids, has varied greatly by state, according to a new study by Columbia University researchers.
Top headlines of the week from Friday, March 7- Thursday, March 13, 2014.
Some addiction experts say the U.S. government’s fight against prescription drug abuse may have inadvertently contributed to the rise in heroin use, according to The Washington Post.
The number of young adults in the U.S. taking medications for attention deficit hyperactivity disorder (ADHD) nearly doubled from 2008 to 2012, according to Express Scripts, the nation’s largest prescription drug manager, The New York Times reports.
West Virginia Senator Joe Manchin this week called on Health and Human Services Secretary Kathleen Sebelius to overrule the Food and Drug Administration’s decision to approve the pure hydrocodone drug Zohydro ER (extended release).
A new survey of affluent women treated for alcohol and drug addiction finds prescription medication and heroin are their leading drugs of choice.
We have witnessed substance abuse problems spread from community to community, seemingly unabated. The National Rx Drug Abuse Summit is helping to meet challenges head-on through an unprecedented collaboration, says Dan Smoot of Operation Unite.